This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.This clinical trial is being conducted to satisfy the Food and Drug Adminisration (FDA) requirements for accelerated approval of the CSL Influenza Vaccine in the US. In order to obtain an indication for healthy adults, CSL must conduct a placebo-controlled study to meet defined immunogenicity outcomes for all 3 influenza vaccine strains. (Thimerosal-free)
Showing the most recent 10 out of 515 publications